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Alcohol consumption combined with inactive aldehyde dehydrogenase-2 (ALDH2) and the
presence of multiple esophageal Lugol-voiding lesions (LVLs; dysplasia) are strong predic-
tors for multiple development of esophageal squamous cell carcinoma (ESCC) in East
Asians. We invented a health risk appraisal (HRA) model for predicting the risk of ESCC
based on drinking, smoking, dietary habits, and alcohol flushing, i.e., past or present facial
flushing after drinking a glass of beer, a surrogate marker for inactive ALDH2.
Methods
Prospective follow-up examinations (median follow-up time, 50.3 months) were performed
in 278 Japanese men after endoscopic mucosectomy for early ESCC (UMIN Clinical Trials
Registry ID: UMIN000001676).
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Results
Sixty-four subjects developed metachronous ESCC. A receiver operating characteristic
curve showed that HRA scores12 best predicted the development of metachronous
ESCC. The ESCC detection rate per 100 person-years was 9.8 in the high-HRA-score
group (n = 104) and 4.5 in the low-HRA-score group (n = 174), and the risk of development
of metachronous ESCC was higher in the high-HRA-score group than in the low-HRA-score
group (adjusted hazard ratio: 2.00 [95% CI: 1.12–3.30]). Multiple LVLs was a very strong
predictor of the development of metachronous SCC, but high HRA scores predicted it inde-
pendently. The cumulative incidences of metachronous ESCC decreased after drinking ces-
sation in the high-HRA-score drinker group (adjusted hazard ratio: 0.37 [0.14–0.97]).
Conclusions
Both the HRA model that included alcohol flushing and the multiple LVL grade predicted the
development of metachronous ESCC in Japanese men after endoscopic mucosectomy for
ESCC. Drinking cessation in the high-HRA-score drinker group reduced the rate of meta-
chronous ESCC.
Introduction
Technical improvements in endoscopes and a growing understanding of the endoscopic fea-
tures of early squamous cell carcinoma (SCC) in the upper aerodigestive tract (UAT) have
enabled early detection of SCC in the UAT [1,2]. Although treatment of early esophageal SCC
by endoscopic mucosectomy has become a widespread practice in Japan and has succeeded in
improving the outcome of this high-mortality cancer [3–5], follow-up endoscopic examina-
tions have revealed an extremely high rate of development of metachronous SCC in the
remaining esophagus and the head and neck [6–11]. Our recent prospective cohort study of
patients who had undergone endoscopic mucosetcomy for early esophageal SCC demon-
strated a strong association between the cumulative incidence of metachronous esophageal
SCC and the grade of esophageal Lugol-voiding lesions (LVLs; squamous cell dysplasia)
assessed by Lugol chromoendoscopy [12]. In addition, drinking cessation decreased the rate of
developing metachronous esophageal SCC [12].
Aldehyde dehydrogenase-2 (ALDH2) is a major enzyme in the metabolism of acetaldehyde
after alcohol consumption, an established human carcinogen for SCC in the UAT [13]. A
mutant allele (ALDH22; rs671) encodes an inactive subunit, and alcohol consumption by East
Asians who are inactive ALDH22 carriers markedly increases their risk of SCC in the UAT
[8,11,14–20]. We devised a simple alcohol flushing questionnaire for predicting the presence
of inactive ALDH2 [21,22], and a health risk appraisal (HRA) model for esophageal SCC that
consists of alcohol flushing and drinking, smoking, and dietary habits was developed based on
the results of a Japanese male case-control study ([23]; Fig 1). In that study 58% of the esoph-
ageal SCC cases had HRA scores in the top 10% of the scores of the controls (an HRA score
11). Cross-sectional and follow-up mass-screening studies have shown very high esophageal
SCC detection rates in groups with high-HRA-scores, i.e., scores11 [24,25].
Higher risks of developing metachronous [8,11,12,26] and multiple [27–31] SCC in the
UAT of Japanese subjects with esophageal SCC have been found to be associated with the pres-
ence of ALDH22, drinking, smoking, and lower fruit intake.
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We therefore hypothesized that the risk of the first esophageal SCC assessed on the basis of
the HRA score affected the risk of a second esophageal SCC after endoscopic mucosectomy for
the first esophageal SCC.
The aim of this prospective study was to determine whether and to what extent the HRA
score before the time of the first diagnosis of esophageal SCC alone or combined with the LVL
grade predicts the development of metachronous esophageal SCC in male patients who have
undergone endoscopic mucosectomy for early esophageal SCC. We also evaluated the effect of
drinking cessation during the follow-up period combined with the initial HRA score on the
development of metachronous esophageal SCC.
Materials and methods
Study design
From September 2005 to May 2010, we prospectively recruited patients of both sexes from 16
hospitals throughout Japan. This cohort study was approved by the institutional review board
at each hospital; the Ethics Committee of National Hospital Organization Kurihama Medical
and Addiction Center, the Ethics Committee of Kitasato University School of Medicine, the
Ethics Committee of National Institute of Public Health, the Ethics Committee of National
Fig 1. HRA model for predicting esophageal squamous cell carcinoma (SCC). The risk score is calculated as the sum of scores A to E.
Higher scores mean higher risk of esophageal SCC.
https://doi.org/10.1371/journal.pone.0175182.g001
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Cancer Center Hospital East, the Ethics Committee of National Cancer Center Hospital, the
Ethics Committee of Hokkaido University Graduate School of Medicine, the Ethics Commit-
tee of Ishikawa Prefectural Central Hospital, the Ethics Committee of Tohoku University
Graduate School of Medicine, the Ethics Committee of Shizuoka Cancer Center, the Ethics
Committee of National Hospital Organization Osaka National Hospital, the Ethics Committee
of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,
the Ethics Committee of Kanagawa Cancer Center, the Ethics Committee of Showa University
School of Medicine, the Ethics Committee of Kumamoto Regional Medical Center, the Ethics
Committee of St. Marianna University School of Medicine, the Ethics Committee of Kawasaki
Municipal Hospital, the Ethics Committee of Tochigi Cancer Center, the Ethics Committee of
Keio University School of Medicine, the Ethics Committee of Kyoto Prefectural University of
Medicine, and the Ethics Committee of Kyoto University Graduate School of Medicine. We
obtained a written informed consent from each patient (UMIN Clinical Trials Registry ID:
UMIN000001676) [12].
Study population
The referent cohort consisted of 332 patients of both sexes who had undergone complete
endoscopic mucosectomy of early esophageal SCC. The inclusion criteria have been stated in
an earlier report [12]. We selected the 278 male patients as the subjects of this study, because
the HRA model evaluated in this study had been devised based on the results of an earlier
study of esophageal SCC in men.
LVL grading
LVLs were graded according to the maximum number of LVLs in at least one endoscopic field
of view (A = no lesions; B = 1 to 9 lesions; C =10 lesions). Endoscopic images obtained from
the subjects at study entry were centrally reviewed in a blinded fashion by three endoscopists
to grade the LVLs.
HRA score
At the time of the baseline registration each subject was asked to fill out a structured question-
naire that asked questions concerning alcohol flushing response, drinking habits, smoking
habits, and vegetable and fruit intake prior to the time of the first diagnosis of esophageal SCC.
The questionnaire was the same as used in the earlier case-control study on which the HRA
model was based [21,23]. The questionnaire asks whether the subject had a past or has a cur-
rent tendency for facial flushing to occur after drinking a glass ( 180 ml) of beer, a surrogate
marker of inactive ALDH2, and both the sensitivity and specificity of the flushing question-
naire as a means of identifying inactive ALDH2 in Japanese populations are approximately
90%. The HRA score was calculated as the sum of the scores A to E in Fig 1 which are loga-
rithms of the multivariate odds ratio of each factor estimated in the previous case-control
study.
Follow-up examinations
Follow-up surveillance in the form of an endoscopic examination of the esophagus and Lugol
chromoendoscopy was performed at 3-month intervals until 6 months after endoscopic muco-
sectomy of the initial esophageal SCC, and it was repeated every 6 months thereafter. If a new
esophageal SCC was detected at the time of the first follow-up examination or thereafter, and
was localized without continuity with the initial esophageal SCC, a diagnosis of
HRA mode, drinking cessation, and metachronous cancer
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“metachronous” SCC was made. SCC lesions present at registration as well as new lesions were
centrally reviewed and confirmed in a blinded fashion by three pathologists.
Alcohol and smoking cessation
At study entry, the physicians in charge handed a document describing the importance of ces-
sation of drinking and smoking to all subjects and verbally instructed them to stop drinking
and smoking. At each examination, we surveyed smoking status (non-smoker or smoker; and
for smokers, the number of cigarettes smoked per day) and drinking status (nondrinker or
drinker; and for drinkers, drinking frequency and amount of alcohol consumed) by self-report
and instructed the subjects not to drink or smoke. The serum gamma-glutamyl transpeptidase
(GGT) level was also measured at each examination.
Statistical analysis
The data analysis in this study was performed 24 months after the endoscopic mucosectomy
for the first esophageal SCC of the most-recently registered subject. Data are expressed as the
mean ± SD or as a percentage. The geometric mean and geometric SE were calculated for
GGT values that were log-normally distributed.A time-dependent receiver operating charac-
teristic (ROC) curve at 24 months was used to assess the performance of the HRA model for
predicting the development of metachronous esophageal SCC and to determine the optimal
cut-off value [32]. Student’s t-test was used to compare the mean ages of different groups.
P values for categorical data were calculated by using the Cochran-Mantel-Haenszel test for
trends in LVL grade and Fisher’s exact test for other variables. The 95% confidence interval
(95% CI) of the detection rate was estimated and tested based on a Poisson distribution. Cum-
ulative percentages of patients with metachronous esophageal SCC were calculated according
to the Kaplan-Meier method, and groups were compared by the log-rank test. The multivariate
Cox proportional-hazards model was used to estimate the hazard ratio and 95% CI. All analy-
ses were performed by using the SAS statistical package (version 9.1; SAS Institute, Cary, NC).
Results
The median follow-up period was 50.3 months (range, 1.3–81.2 months), and 64 subjects were
diagnosed with metachronous esophageal SCC. Fig 2 shows the time-dependent ROC curve of
the HRA model for predicting having developed metachronous esophageal SCC at 24 months,
because the data analysis was performed 24 months after the endoscopic mucosectomy for the
first esophageal SCC of the most-recently registered subject. The sensitivity of this possible
predictor increased with a relatively small increase in the false-positive rate above the HRA
score cutoff point of 12, at which the sensitivity was 67.3% and the false-positive rate was
32.7%. We therefore used an HRA score cutoff point of12 in the following analyses.
HRA scores12 selected 104 subjects (37.4%). Based on the cutoff points reported for
mass-screening programs [23–25], HRA scores11 selected 46.0% of the subjects, and when
HRA scores were used as a cutoff point of 9 in the group aged 69 years and under and 8 in the
group aged 70 years and over, 72.3% of the subjects were selected.
Table 1 summarizes the baseline characteristics of the subjects according to their HRA
scores. The high-HRA-score group, i.e., group with scores12, was characterized by heavier
alcohol consumption, especially among current or former flushers, a greater preference for
drinking strong alcoholic beverages straight, more cigarette smoking, and less intake of green
and yellow vegetables and fruit. The LVL grade C was more common in the high-HRA-score
group than in the low-HRA-score group. There were no significant differences in the propor-
tions of abstainers from alcohol among those who had drunk 1 unit or more per day at baseline
HRA mode, drinking cessation, and metachronous cancer
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between the high- and low-HRA-score groups. The latest serum GGT levels of the abstainer
group were significantly lower than in the non-abstainer group (geometric mean [geometric
SE] = 26.5 [1.09] and 41.6 [1.08] IU/L, respectively, p<0.0001). There were no significant dif-
ferences in the proportions of abstainers from tobacco among those who had smoked at base-
line between the high- and low-HRA-score groups.
High HRA scores were associated with increases in the total number (95% CI) of metachro-
nous esophageal SCC per 100 person-years (high-HRA-score group vs. low-HRA-score group;
9.8 [6.8–13.7] vs. 4.5 [3.0–6.5], p = 0.002; Table 2).
The cumulative incidences of metachronous esophageal SCC were significantly higher in
the high-HRA-score group (p = 0.001; Fig 3).
When LVL grades and HRA scores were simultaneously entered into a multivariate Cox
proportional-hazards model, LVL grade C was the strongest predictor of metachronous
esophageal SCC (multivariate hazard ratio [95% CI]: 14.1 [1.93–103]; Table 3), but high HRA
scores were an independent predictor of metachronous esophageal SCC (multivariate hazard
ratio [95% CI] = 2.00 [1.21–3.30]). When LVL grades, HRA scores, and drinking cessation
were simultaneously entered into the multivariate model for the group who had drunk 1 unit
or more per day at baseline, drinking cessation was found to independently decrease the
risk of metachronous esophageal SCC (multivariate hazard ratio [95% CI]: 0.45 [0.22–0.89]).
Fig 2. Time-dependent receiver operating characteristic curve according to HRA score at 24 months for
predicting metachronous esophageal squamous cell carcinoma (SCC) in patients who had undergone
endoscopic mucosectomy for early esophageal SCC.
https://doi.org/10.1371/journal.pone.0175182.g002
HRA mode, drinking cessation, and metachronous cancer
PLOS ONE | https://doi.org/10.1371/journal.pone.0175182 April 6, 2017 6 / 14
Table 1. Clinical characteristics of subjects according to HRA score.
HRA score
Total Low (0–11) High (12) P a
(n = 278) (n = 174) (n = 104)
Age (years)
40–59 16.9% 13.8% 22.1%
60–69 45.3% 42.5% 50.0%
70+ 37.8% 43.7% 27.9% 0.019
Mean±SD 66.7±7.9 67.6±7.9 65.3±7.7 0.020
Current or former flushers (n = 179) (n = 85) (n = 94)
Never/rare drinkers b 5.0% 10.6% 0.0%
Light drinkers 19.0% 40.0% 0.0%
Moderate drinkers 32.4% 31.8% 33.0%
Heavy drinkers 33.0% 3.5% 59.6%
Ex-drinker 10.6% 14.1% 7.4% <0.0001
Never flushers (n = 99) (n = 89) (n = 10)
Never/rare drinkers b 0.0% 0.0% 0.0%
Light drinkers 12.1% 13.5% 0.0%
Moderate drinkers 27.3% 30.3% 0.0%
Heavy drinkers 52.5% 49.4% 80.0%
Ex-drinker 8.1% 6.7% 20.0% 0.026
Strong alcoholic beverage consumption
Frequent 11.9% 3.4% 26.0%
Sometimes or never 88.1% 96.6% 74.0% <0.0001
Smoking (pack years)
<30 28.1% 37.9% 11.5%
30 71.9% 62.1% 88.5% <0.0001
Green-yellow vegetable consumption
Seldom to 3–4 days/week 61.5% 50.0% 80.8%
Almost every day 38.5% 50.0% 19.2% <0.0001
Fruit consumption
Seldom to 3–4 days/week 73.0% 63.2% 89.4%
Almost every day 27.0% 36.8% 10.6% <0.0001
LVL grade
A 11.2% 13.2% 7.7%
B 53.2% 55.7% 49.0%
C 35.6% 31.0% 43.3% 0.025
Drinking cessationc (n = 212) (n = 117) (n = 95)
No 70.3% 73.5% 66.3%
Yes 29.7% 26.5% 33.7% 0.29
Smoking cessationd (n = 119) (n = 58) (n = 61)
No 45.4% 41.4% 49.2%
Yes 54.6% 58.6% 50.8% 0.46
HRA, health risk appraisal; LVL, Lugol-voiding lesion.
a P-values are by t-test (mean age), Cochran-Mantel-Haenszel test for trend (LVL grade), or Fisher’s exact test (other variables).
b Never/rare, <1 unit/week; light, 1–8.9 units/week; moderate, 9–17.9 units/week; heavy,18 units/week (1 unit = 22 grams ethanol).
c Among those who had drunk 1 unit or more per day at baseline.
d Among those who had smoked at baseline.
https://doi.org/10.1371/journal.pone.0175182.t001
HRA mode, drinking cessation, and metachronous cancer
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Smoking cessation in the group who had smoked at baseline did not affect the risk of meta-
chronous esophageal SCC.
The cumulative incidences of metachronous esophageal SCC were markedly reduced by
drinking cessation in the high-HRA-score group who had drunk 1 unit or more per day at
baseline (Fig 4), and after adjustment for age and LVL grades the hazard ratio (95% CIs) for
metachronous esophageal SCC was also reduced by drinking cessation (0.37 [0.14–0.97],
p = 0.042) in this group. Drinking cessation among the low-HRA-score group did not affect
the cumulative incidences of metachronous esophageal SCC.
Table 2. Person-years and numbers of metachronous SCC in the esophagus according to HRA score.
HRA score
Total Low (0–11) High (12) P
Metachronous SCC (n = 278) (n = 174) (n = 104)
No. of events 64 29 35
Person-years 998.3 642.2 356.1
Per 100 person-years 6.4 4.5 9.8 0.002
(95% CI) (4.9–8.2) (3.0–6.5) (6.8–13.7)
HRA, health risk appraisal; SCC, squamous cell carcinoma.
https://doi.org/10.1371/journal.pone.0175182.t002
Fig 3. Cumulative incidences of metachronous esophageal squamous cell carcinoma in the
esophagus according to HRA score. Hazard ratio was adjusted for age and LVL grades.
https://doi.org/10.1371/journal.pone.0175182.g003
HRA mode, drinking cessation, and metachronous cancer
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Discussion
The development of multiple SCCs in the UAT has been known as the phenomenon of “field
cancerization” [33] and decreases the survival rate [26]. The results of follow-up studies of
Table 3. Prediction of metachronous SCC in the esophagus based on Cox proportional hazards models.
Metachronous SCC Multivariate model 1 (n = 278) Multivariate model 2 (n = 212) Multivariate model 3 (n = 119)
HR (95% CI) a HR (95% CI) a HR (95% CI) a
LVL grade A 1 (ref.) 0.00 (NC) 0.00 (NC)
B 4.76 (0.64–35.3) 1 (ref.) 1 (ref.)
C 14.1 (1.93–103) 3.23 (1.78–5.83) 4.17 (1.92–9.08)
P for trend <0.0001 <0.0001
HRA score Low (0–11) 1 (ref.) 1 (ref.) 1 (ref.)
High (12) 2.00 (1.21–3.30) 2.17 (1.24–3.81) 1.91 (0.92–3.97)
P value 0.007 0.007 0.085
Drinking cessation No 1 (ref.)
Yes 0.45 (0.22–0.89)
P value 0.023
Smoking cessation No 1 (ref.)
Yes 0.71 (0.35–1.45)
P value 0.35
HR, hazard ratio; CI, confidence interval; LVL, Lugol-voiding lesion; SCC, squamous cell carcinoma.
NC, it was impossible to calculate the 95% CI because of the zero number of events in the LVL grade A group.
Model 1: all subjects.
Model 2: subjects who had drunk 1 unit or more per day at baseline.
Model 3: subjects who had smoked at baseline.
a Grade of LVLs, HRA score, and drinking cessation (model 2) or smoking cessation (model 3) were simultaneously entered into a multivariate Cox
proportional-hazards model; an adjustment was made for age but is not shown in this table.
https://doi.org/10.1371/journal.pone.0175182.t003
Fig 4. Cumulative incidences of metachronous esophageal squamous cell carcinoma in the esophagus according to drinking
status in the high-HRA-score drinker group and in the-low-HRA-score drinker group. Hazard ratios were adjusted for age and LVL
grades.
https://doi.org/10.1371/journal.pone.0175182.g004
HRA mode, drinking cessation, and metachronous cancer
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Japanese patients who had undergone endoscopic mucosectomy for early esophageal SCC
have showed a very high prevalence of metachronous SCC in the UAT [6–11]. The results of
the present prospective study showed that high HRA scores, i.e.,12, were associated with a
two-fold higher risk of metachronous esophageal SCC. The esophageal SCC detection rate was
much higher (9.8 per 100 person-years) in the high-HRA-score group. These results suggest
that the risk of a first esophageal SCC assessed on the basis of the HRA scores to a considerable
extent remains in regard to a second esophageal SCC.
As we have recently reported [12], the results of a present study showed that the highest
LVL grade, i.e., grade C, was associated with a markedly high risk of metachronous esophageal
SCC. High HRA scores12 were positively associated with the LVL grade. However, the
strong effect of high HRA scores on metachronous esophageal SCC was independent of the
effect of LVL grades on metachronous esophageal SCC.
The HRA score was calculated based on the multivariate odds ratio of each risk factor esti-
mated in the previous case-control study of esophageal SCC [15,21,23]. Calculating HRA
scores makes it possible for people to identify their risk of esophageal SCC easily, and can be
easily applied to public education or mass-screening. Follow-up chromoendoscopy was per-
formed on 404 cancer-free controls in the original study, and the esophageal SCC detection
rate per 100 person-years was 2.32 in the group with HRA scores11 and 0.13 in the group
with HRA scores<11 [24]. We applied the HRA questionnaire to endoscopic mass-screening
of 2,221 Japanese men at 5 cancer screening facilities, and esophageal SCC was detected in
4.3% of the group with HRA scores11, as opposed to 0.7% of the group with HRA scores
<11 [25].
HRA scores11 identified 58% of the esophageal SCC cases in the original case-control
study [23], and in the present study HRA scores11 identified 46.0% of the subjects. Since the
HRA scores11 have been found in 5–11% of Japanese male populations [23–25], the subjects
of the present study had a very high background risk for esophageal SCC.
Previous Japanese studies have consistently demonstrated that the LVL grade C [6,7,9,10,
27–29] and alcohol drinking with inactive heterozygous ALDH2 [8,11,27–31], which were
associated with each other [20,27,29], were two strong risk factors for field cancerization in the
UAT. Current or former flushing tendency after drinking a glass of beer, a surrogate marker of
inactive ALDH2, identified inactive ALDH2 with 90% accuracy [21], and a very high risk of
SCC in the UAT has been demonstrated in moderate or heavy drinkers who are current or for-
mer flushers [21,22,34]. Such high-risk drinkers accounted for 83.7% of the group with HRA
scores12 in the present study and 17.2% of the group with scores<12. Japanese studies have
shown stronger associations between esophageal SCC and preference for drinking strong alco-
holic beverages (whiskey and shochu) straight [15,34], which suggests the role of direct intact
of high levels of acetaldehyde as an carcinogenic ingredient in whiskey and shochu [35]. There
is substantial evidence that smoking and poor intake of green and yellow vegetables and fruit
increase the risk of esophageal SCC [36,37]. All of the above risk factors were more common
in the high-HRA-score group in this study, and that explains the good performance of the
HRA score in predicting the risk of metachronous esophageal SCC.
We have reported that drinking cessation after endoscopic mucosectomy for early esoph-
ageal SCC substantially reduced the risk of metachronous SCC among drinkers, especially
among those with LVL grade C [12]. A recent meta-analysis showed that the alcohol-related
increased risk of esophageal cancer is reversed by alcohol cessation and the time-response rela-
tionship showed an exponential decay [38]. In the present study, drinking cessation in the
high-HRA-score drinker group markedly reduced the risk of metachronous esophageal SCC.
Informing high-risk persons of their high HRA scores will help persuade them to undergo fol-
low-up examinations and change their lifestyle to prevent metachronous SCC. Smoking
HRA mode, drinking cessation, and metachronous cancer
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cessation did not significantly reduce the risk of metachronous esophageal SCC. Most epide-
miologic studies have shown that the increased risk of esophageal SCC persisted for many
years after smoking cessation and declined thereafter [39]. Drinking and smoking have a syn-
ergistic effect in increasing the risk of esophageal SCC [40], but drinking combined with alco-
hol flushing or inactive ALDH2 has an even greater effect [15, 17, 23]. It is conceivable that the
very high prevalence of current or former flushers among the high-HRA-score drinkers con-
tributed greatly to reducing their risk of metachronous esophageal SCC after drinking cessa-
tion. The time lag after which the risk reduction occurs and the magnitude of the reduction
may partly account for the different effects of drinking cessation and smoking cessation. An
investigation of the effectiveness of changing lifestyles is warranted.
Our follow-up study had several potential limitations. Although most of the subjects were
followed-up for at least 24 months, and the median follow-up time was 50.3 months, there
was wide individual variability in the follow-up period due to the 4.3-year subject registration
period. The follow-up time variability may have limited the assessment of the relationship
between the HRA scores and actual rate of metachronous SCC development. A longer term
prospective study of the present cohort is currently under way. Recall bias and the reliability of
self-reported drinking and smoking status are always problematic. However, we were able to
confirm lower serum GGT levels in the abstainers. We excluded female patients from the refer-
ent population. ALDH2-related susceptibility to esophageal SCC has been demonstrated in
Asian female drinkers [18,41,42]. A much smaller proportion of women who are heterozygous
for ALDH2 than of men are drinkers [15,41]. Designing an HRA model for females will be the
task of a future study.
In conclusion, the HRA model we devised for assessing the risk of esophageal SCC and the
LVL grade were found to be good predictors of the development of metachronous esophageal
SCC in Japanese men who had undergone endoscopic mucosectomy for early esophageal
SCC. Drinking cessation in the high-HRA-score drinkers reduced the risk of metachronous
esophageal SCC.
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